Viraemia and p24 antigenaemia are independent risk factors for the emergence of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection

  1. Relimpio, F.
  2. Rey, C.
  3. Pineda, J.A.
  4. Leal, M.
  5. Caruz, A.
  6. Sánchez-Quijano, A.
  7. Lissen, E.
Aldizkaria:
Antiviral Therapy

ISSN: 1359-6535

Argitalpen urtea: 1997

Alea: 2

Zenbakia: 2

Orrialdeak: 99-104

Mota: Artikulua